Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII)
070701
Phase 1 mab completed
Quick answer
Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII) for Von Willebrand Disease is a Phase 1 program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Von Willebrand Disease
- Phase
- Phase 1
- Modality
- mab
- Status
- completed